Full-Time

Quality Control Reviewer

Sample Management

Updated on 8/1/2026

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Laval, QC, Canada

In Person

Category
Lab & Research (1)
Required Skills
Microsoft Office
FDA Regulations
Microsoft Outlook

Get referred to Altasciences

See people who can refer or advise you

Requirements
  • A high school diploma or higher in health sciences or an equivalent qualification, with at least 3 years of experience.
  • In-depth knowledge of FDA good laboratory practice, good clinical practice, and Therapeutic Products Directorate regulations.
  • Experience in the medical or pharmaceutical field is an asset.
  • Excellent management, organizational, written and oral communication, and interpersonal skills.
  • A strong good laboratory practice and good clinical practice focus.
  • Strong leadership, decision-making, and problem-solving skills.
  • Bilingual French and English language proficiency.
  • Proficiency with Access, Outlook, Microsoft Office, and Watson.
Responsibilities
  • Perform 100% quality control on documentation generated by the sample management team.
  • Be responsible for quality within the sample management team.
  • Perform audits within the team by developing, executing, and writing audit reports.
  • Complete additional information forms as necessary to ensure documentation is accurate and complete.
  • Complete documentation necessary to track deviations and non-conformance reports within the team.
  • Respond to quality assurance citations.
  • Archive documentation.
  • Write, revise, and/or review standard operating procedures for sample management and glass washing.
  • Write, revise, and/or update training materials.
  • Keep abreast of relevant regulatory developments in the industry.
  • Perform all work in accordance with applicable standard operating procedures, good clinical practice, and good laboratory practice requirements, and adhere to company guidelines and policies.
  • Keep abreast of new standard operating procedures, procedures, and techniques through training sessions, meetings, and internal communications.
Desired Qualifications
  • Experience in the medical or pharmaceutical field.

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Get referred to Altasciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic Certara partnership embeds biosimulation to enable earlier proof of mechanism and refined dosing.
  • RegulatoryFlow AI from Evidence Matters automates one-third of nonclinical reports to expedite timelines.
  • 258 active hiring postings in 2025 signal capacity expansion supporting integrated model and growth.

What critics are saying

  • Certara integration enables sponsors to make go/no-go decisions earlier, reducing later-phase trial volume and revenue.
  • AI tools like RegulatoryFlow and Instill erode preclinical consulting margins and program management revenue by 20–30%.
  • Smaller CROs expanding early-phase with lower pricing may force loss of 15–25% of Phase I contracts in 6–12 months.

What makes Altasciences unique

  • Fully integrated CRO/CDMO spans preclinical to clinical proof of concept under one supplier.
  • Proprietary Acceleration Platform reduces timelines by 25–40% via parallel execution and single-point contact.
  • Eight global facilities and 1,800+ employees deliver 98% on-time delivery for early-phase trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

8%
GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.